Late-Breaking Abstract Guidelines
Placeholder Deadline: Monday, February 22, 2027, at 11:59pm ET
Final Deadline: Friday, April 9, 2027, at 5:00pm ET
SNO recognizes that some rapidly advancing investigations may include results that will not be available at the time of February 22, 2027, abstract submission deadline. For this reason, SNO will allow authors to submit their late-breaking clinical trial research for consideration for the 2027 EANO-SNO Joint Meeting on Pediatric Neuro-Oncology.
Late-breaking submissions must adhere to guidelines below and a placeholder abstract must be submitted by the initial February 22 submission deadline. Late-breaking abstracts will not be accepted if a placeholder abstract is not submitted by February 22, 2027.
Abstracts that are not clinical trials following interim or final analysis may not be submitted as Late Breaking abstracts and may be rejected.
Please note that only a limited number of abstracts from this late-breaking category will be selected for oral presentation at the meeting. Authors should note the following important information before submitting a late-breaking abstract:
For an abstract to be considered for Late-Breaking Abstract status, the submitting author must: